Chronic pulmonary coccidioidomycosis is a disease caused by breathing in a fungus found in the soil in certain parts of the southwestern U.S., Mexico, and Central and South America that can cause a chronic lung (pulmonary) condition.
Causes, incidence, and risk factors
The infection is caused by breathing in the spores of a fungus found in desert regions such as Arizona or California’s San Joaquin Valley. The disease can have an acute, chronic, or disseminated form.
The chronic form usually develops after a latent period of months to years following an initial benign infection which may go undiagnosed. Lung abscesses may form and may rupture into the pleural spaces causing empyema (pus in the pleural space) or bronchopleural fistula. Scarring (fibrosis) and cavities may gradually form in the upper lungs as the chronic form of coccidioidomycosis slowly progresses over months to years.
Still, the majority of pulmonary coccidioidomycosis infections do not become chronic. In fact, the majority of infections cause no symptoms and are only recognized by a positive coccidioidin skin test.
Dark skinned people and people with a weak immune system are more susceptible to infection and more likely to form chronic or disseminated (spreading to other organs) forms of the disease.
- chronic cough
- blood tinged sputum
- loss of appetite
- weight loss
- shortness of breath
Additional symptoms that may be associated with this disease:
- sweating, excessive
- joint stiffness
- chest pain
Signs and tests
- sputum smear (KOH test)
- sputum fungal culture
- serum coccidioides complement fixationtiter (serology)
- CBC with differential
- chest X-ray
- chest CT scan
- coccidioidin or spherulin skin test
- bronchoscopy with transbronchial biopsy
- open lung biopsy
- lumbar puncture (spinal tap) to exclude meningitis involvement
Antifungal medications are prescribed to treat the infection. The intravenous antibiotic, Amphotericin B, is used for severe forms of disease. Itraconazole and fluconazole are oral antibiotic options with activity against this fungus. Ketoconazole is another option, but appears less effective. Treating any underlying immunocompromised state (such as AIDS) and minimizing immunosuppressant medications (such as steroids or chemotherapy) is also crucial if the patients immune system is to properly fight the coccidioidomycosis fungal infection.
With treatment the outcome is usually good although relapses may occur. Some patients, such as those who are immunocompromised (from AIDS or immunosuppressing drugs) may need life-long anti-fungal medication to prevent relapse.
- pleural effusion
- relapse of infection
- coccidioidomycosis; disseminated
- coccidioidomycosis meningitis
- bronchopleural fistula
- lung scarring (fibrosis)
- lung cavities
Calling your health care provider
Call for an appointment with your health care provider if coccidioidomycosis symptoms worsen or do not improve with treatment.
Call your health care provider if new symptoms develop.
As coccidioidomycosis usually causes no symptoms, or in the majority of symptomatic infections usually resolves quickly on its own without causing significant symptoms there is generally no need to avoid infection. Immunocompromised people (such as AIDS patients and those on immunosuppressing drugs) may avoid travel to regions where this fungus is found, if they wish to minimize any risk of developing this rare, chronic disorder.
by Janet G. Derge, M.D.
All ArmMed Media material is provided for information only and is neither advice nor a substitute for proper medical care. Consult a qualified healthcare professional who understands your particular history for individual concerns.